NA

Inari Medical IncNASDAQ NARI Stock Report

Last reporting period 30 Jun, 2024

Updated 19 Sep, 2024

Last price

Market cap $B

2.57

Small

Exchange

XNAS - Nasdaq

View Section: Financials

Inari Statements

NA

Inari Income Statement

B

M

USD (except Earnings per share)

Financial

Revenue

Cost of sales

Gross profit

Research and development

Selling, general and administrative

Total operating expenses

Operating income

Interest expense

Other income

Income before tax

Provision for income taxes

Net income

Diluted earnings per share

Shares outstanding after dilution

2024-06-30
%

145.82

100

19.993

13.7

125.83

86.3

24.905

17.1

113.05

77.5

147.24

101

-21.408

-14.7

0.999

0.7

0.023

0.02

-21.422

-14.7

9.926

6.8

-31.348

-21.5

-0.539

58.142

2024-03-31
%

143.19

100

18.893

13.2

124.3

86.8

26.88

18.8

101.95

71.2

138.7

96.9

-14.398

-10.05

1.113

0.8

-0.023

-0.02

-16.087

-11.2

8.115

5.7

-24.202

-16.9

-0.418

57.938

2023-12-31
%

132.09

100

17.006

12.9

115.09

87.1

22.892

17.3

89.96

76

113.98

94.2

1.103

-7.04

6.145

2

-0.022

2.6

-3.174

-2.4

1.491

1.1

-4.665

-3.5

-0.081

57.648

2023-09-30
%

126.4

100

14.5

11.5

111.9

88.5

21.5

17

87.1

68.9

109.8

86.9

2.1

1.7

4.2

3.3

-0.1

-0.08

5.6

4.4

2.4

1.9

3.2

2.5

0.05

58.6

2023-06-30
%

119

100

13.8

11.6

105.2

88.4

21.1

17.7

84.5

71

106.7

89.7

-1.5

-1.3

4.5

3.8

0

3

2.5

0.9

0.8

2.1

1.8

0.04

58.5

2023-03-31
%

116.2

100

13.7

11.8

102.4

88.1

22.1

19

84.6

72.8

107.8

92.8

-5.3

-4.6

4.1

3.5

0

-1.2

-1.03

1

0.9

-2.2

-1.9

-0.04

54.8

2022-12-31
%

107.8

100

13.1

12.2

94.6

87.8

20.4

18.9

79.1

73.4

100.6

93.3

-5.9

-5.5

0.9

0.8

0.2

0.2

-4.8

-4.5

1

0.9

-5.8

-5.4

-0.11

53.7

2022-09-30
%

96.2

100

11.1

11.5

85.1

88.5

19.1

19.9

74.9

77.9

94.9

98.6

-9.8

-10.2

0.5

0.5

-0.1

-0.1

-9.3

-9.7

0.8

0.8

-10.2

-10.6

-0.19

53.5

2022-06-30
%

92.7

100

10.3

11.1

82.4

88.9

18.6

20.1

72.2

77.9

91.8

99

-9.3

-10.03

0.1

0.1

0.3

0.3

-8.9

-9.6

1.3

1.4

-10.2

-11.003

-0.19

53.2

2022-03-31
%

86.8

100

10

11.5

76.8

88.5

16.1

18.5

62.9

72.5

79.8

91.9

-3.1

-3.6

0

0

-3.1

-3.6

0

-3.1

-3.6

-0.06

51

2021-12-31
%

83.2

100

8.3

10

74.9

90

18.7

22.5

53.7

64.5

73.2

88

1.7

2

-0.1

-0.1

0

1.7

2

0.6

0.7

1.1

1.3

0.02

50.3

2021-09-30
%

72.9

100

7

9.6

65.9

90.4

12.5

17.1

55.4

76

68.6

94.1

-2.7

-3.7

0

0

-2.7

-3.7

0.1

0.1

-2.8

-3.8

-0.06

50

2021-06-30
%

63.5

100

4.8

7.6

58.6

92.3

11.6

18.3

42.3

66.6

54.5

85.8

4.1

6.5

0

0

4.1

6.5

0

4.1

6.5

0.07

55.6

2021-03-31
%

57.4

100

4.6

8

52.8

92

8.2

14.3

36.4

63.4

45.1

78.6

7.7

13.4

0

0

7.7

13.4

0.2

0.3

7.5

13.1

0.13

55.7

2020-12-31
%

48.6

100

3.7

7.6

44.9

92.4

6.5

13.4

31.4

64.6

37.9

78

7

14.4

0

0

7

14.4

0

7

14.4

0.14

51

2020-09-30
%

38.7

100

3.2

8.3

35.5

91.7

5.2

13.4

23.1

59.7

28.4

73.4

7.1

18.3

0

0

6.5

16.8

0

6.5

16.8

0.13

48.7

2020-06-30
%

25.4

100

3.5

13.8

21.9

86.2

3.6

14.2

18.9

74.4

22.5

88.6

-0.6

-2.4

-0.3

-1.2

-2.9

-11.4

-3.8

-15

0

-3.8

-15

-0.08

48.4

2020-03-31
%

27

100

2.7

10

24.2

89.6

3

11.1

16.4

60.7

19.4

71.9

4.8

17.8

-0.3

-1.1

-0.4

-1.5

4.1

15.2

0

4.1

15.2

0.09

46.1

2019-12-31
%

19.9

100

2.1

10.6

17.7

88.9

2.7

13.6

13.9

69.8

16.6

83.4

1.2

6

-0.2

-1.005

-0.4

-2.01

0.4

2

0

0.4

2

0.01

46.1

2019-09-30
%

14.2

100

1.5

10.6

12.7

89.4

1.7

12

10.1

71.1

11.8

83.1

0.9

6.3

-0.2

-1.4

-0.3

-2.1

0.4

2.8

0

0.4

2.8

0.01

46.1

2019-06-30
%

10.1

100

1.3

12.9

8.7

86.1

1.6

15.8

7.8

77.2

9.4

93.1

-0.6

-5.9

-0.2

-2

-0.1

-1

-1

-9.9

0

-1

-9.9

-0.02

46.1

2019-03-31
%

6.9

100

0.9

13

6

87

1.2

17.4

5.4

78.3

6.7

97.1

-0.6

-8.7

-0.2

-2.9

-0.1

-1.4

-0.9

-13.04

0

-0.9

-13.04

-0.02

46.1

View Section: Balance Sheet